Abstract
Over the last two decades, the ethical implications of patents for biological materials and processes have been the subject of spirited public debate between the many individuals and groups on which the patent system impacts. Whereas copyright, trade marks, and other species of Intellectual Property Rights (IPR) are widely acceptable, the patent system evokes criticism from many quarters, especially in relation to the legal protection of inventions in the Life Sciences. Some of these criticisms expressed by prestigious public organisations are addressed here from the patent professional standpoint.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Official Journal of the European Communities, 30 July 1998.
Crespi, R.S. (2000) An Analysis of Moral Issues Affecting Patenting of Inventions in the Life Sciences: A European Perspective, Science and Engineering Ethics 6(2): 157–180
The Ethics of patenting DNA, a Discussion Paper, issued 23 July 2002, Nuffield Council on Bioethics, 28 Bedford Square, London WC1B 3JS
Buckley J. in Reynolds v Herbert Smith, 1903 Reports of Patent Cases RPC 123–128, at p. 126.
Trilateral Co-operation of the US, European, and Japanese Patent Offices, reported in 1988, 7 Biotechnology Law Review, pp. 159–193 at p. 163.
Amgen v Chugai (1989,1991) 13 US Patent Quarterly 2d 1737–1797 and 18 USPQ 2d 1017–1031.
National Institutes of Health (NIH), Working Group on Research Tools, June 4 1998, available at www.nih.gov/news/researchtools/.
Ethical Aspects Of Patenting Inventions Involving Human Stem Cells, Opinion of the European Group on Ethics in Science and New Technologies to the European Commission, Report No. 16, 7 May 2002.
Webber, Philip M. (2003) Embryonic cell patenting, BioScience Law Review 6(3), 2003/2004 BSLR: 87–98.
Biotechnology and Patent Protection, An International Review, OECD 1985. (OECD publications are available from OECD, 2 rue Andre Pascal, 75775 PARIS CEDEX 16, FRANCE)
Intellectual Property, Technology Transfer, and Genetic Resources, OECD 1996.
Genetic Inventions, Intellectual Property Rights and Licensing Practices, OECD 2002.
Heller M. and Eisenberg R. (1998) “Can Patents Deter Innovation? The Anticommons in Biomedical Research”, Science 280 (No 5364): 698–701.
Spier, R.E. (2001) Genes in Court, Science and Engineering Ethics 7: 3–6.
Resnik, D.B. (2001) DNA Patents and Scientific Discovery and Innovation: Assessing Benefits and Risks, Science and Engineering Ethics 7: 29–62.
Merz J.F., Kriss A.G., Leonard D.G.B. and Cho M.K. (2002) “Diagnostic Testing Fails the Test”, Nature 415 (Feb. 7): 577–579, February 7.
Revised Draft Best Practice Guidelines for the Licensing of Genetic Inventions, (Professor Richard Gold) OECD paper DSTI/STP/BIO(2004)9/REV1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crespi, R.S. Ethico-legal issues in biomedicine patenting: A patent professional viewpoint. SCI ENG ETHICS 11, 117–136 (2005). https://doi.org/10.1007/s11948-005-0064-6
Issue Date:
DOI: https://doi.org/10.1007/s11948-005-0064-6